Q32 Bio (QTTB) Financial Statements & Analysis

Q32 Bio Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Q32 Bio Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	53.74	0.00	-6.65	6.65	33.97	2.70	1.67	5.32	0.00
Cost of Revenue	0.00	0.00	31.73	0.00	29.93	0.00	0.00	0.00	0.68
Gross Profit	53.74	0.00	-6.65	6.65	33.97	0.00	1.67	5.32	-0.68
Operating Expenses
Research & Development	19.16	48.14	31.73	35.81	93.09	100.39	89.40	47.95	21.38
Selling, General & Administrative	17.68	17.96	9.88	10.06	6.76	23.67	15.89	16.01	7.60
Operating Expenses	36.84	66.10	41.60	45.88	129.92	124.06	105.29	63.96	28.97
Operating Income	16.90	-66.10	-48.26	-39.23	-95.95	-130.26	-109.94	-59.93	-29.66
Other Income/Expense
Interest Income	2.20	3.90	0.00	0.00	0.00	1.57	6.03	4.35	0.54
Interest Expense	1.10	1.10	-2.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	12.92	18.39	-5.17	-3.52	0.19	1.57	6.03	4.35	-0.33
Income
Income Before Tax	29.82	-47.71	-53.43	-42.75	-37.02	-128.69	-103.92	-55.58	-29.99
Income Tax Expense	0.00	0.02	0.32	0.06	0.55	0.00	0.00	0.00	0.00
Net Income	29.82	-47.73	-53.74	-42.81	-95.76	-128.69	-103.92	-55.58	-29.99
Net Income - Continuous Operations	29.82	-47.73	-53.74	-42.81	-37.56	-128.69	-103.92	-55.58	-29.99
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	31.31	-44.50	-47.76	-38.86	-36.65	-121.36	-97.60	-58.64	-29.31
EBIT	16.90	-66.10	-48.26	-39.23	-36.69	-	-	-	-
Depreciation & Amortization	0.39	0.49	0.50	0.37	0.05	8.90	6.32	1.29	0.68
Earnings Per Share
Basic EPS	2.00	-5.00	-5.00	-4.00	-6.00	-50.00	-44.00	-35.00	-14.00
Diluted EPS	2.00	-7.00	-5.00	-4.00	-31.00	-50.00	-44.00	-35.00	-14.00
Basic Shares Outstanding	12.30	9.32	11.93	11.93	6.47	2.55	2.34	1.59	2.08
Diluted Shares Outstanding	12.31	9.66	11.93	11.93	6.47	2.55	2.34	1.59	2.08

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Q32 Bio Financial Statements

What was Q32 Bio's revenue in fiscal 2025?

Q32 Bio reported revenue of $53.74M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Is Q32 Bio profitable?

Yes. Q32 Bio earned net income of $29.82M in fiscal 2025, a net margin of 55.5%. In fiscal 2024 it lost $47.73M.

What is Q32 Bio's operating margin?

Q32 Bio's operating income was $16.90M on revenue of $53.74M in fiscal 2025, an operating margin of 31.5%.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition